HIV-1 infection and cognitive impairment in the cART era: a review.

作者: Judith Schouten , Paola Cinque , Magnus Gisslen , Peter Reiss , Peter Portegies

DOI: 10.1097/QAD.0B013E3283437F9A

关键词:

摘要: With the introduction of combination antiretroviral therapy AIDS dementia complex or HIV-associated dementia, as it was termed later, largely disappeared in clinical practice. However, past few years, patients, long-term infected and treated, including those with systemically well controlled infection, started to complain about milder memory problems slowness, difficulties concentration, planning, multitasking. Neuropsychological studies have confirmed that cognitive impairment occurs a substantial (15-50%) proportion patients. Among HIV-1-infected patients is one most feared complications HIV-1 infection. In addition, neurocognitive may affect adherence treatment ultimately result increased morbidity for systemic disease. So what be going on CNS after so many years apparently infection an urgent important challenge field HIV medicine. this review we summarize key currently available data. We describe neurological neuropsychological findings, preferred diagnostic approach new imaging techniques cerebrospinal fluid analysis. try integrate data pathogenesis finally discuss possible therapeutic interventions.

参考文章(200)
Françoise Gray, Fabrice Chrétien, Anne Valérie Vallat-Decouvelaere, Francesco Scaravilli, The changing pattern of HIV neuropathology in the HAART era Journal of Neuropathology and Experimental Neurology. ,vol. 62, pp. 429- 440 ,(2003) , 10.1093/JNEN/62.5.429
Cristina Ramondetti, Barbara Buccinnà, Annalisa Anselmino, Lucia Palmisano, Michael Mostert, Maria T Rinaudo, Pier-Angelo Tovo, Emanuela Ricotti, Marco Piccinini, Antonio Dematteis, The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function. Antiviral Therapy. ,vol. 10, pp. 215- 223 ,(2005)
Elona Rrapo, Huayan Hou, Brian Giunta, Jun Tan, Adam Smith, Yuyan Zhu, Francisco Fernandez, Jun Tian, Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice. American Journal of Translational Research. ,vol. 1, pp. 72- 79 ,(2009)
Angrist B, d'Hollosy M, Satriano J, Diamond G, Sanfilipo M, Simberkoff M, Weinreb H, Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. Journal of Clinical Psychopharmacology. ,vol. 12, pp. 268- 272 ,(1992)
Bruce J. Brew, AIDS dementia complex. Handbook of Clinical Neurology. ,vol. 85, pp. 79- 91 ,(2007) , 10.1016/S0072-9752(07)85006-8
Paul Satz, Justin C. McArthur, David W. Johnson, James T. Becker, Eric Miller, Barbara Visscher, Tish Nance-Sproson, Ola A. Seines, Danna Starkey, Bruce A. Cohen, Charles Herman, Sue Bass, Alfred Saah, Kathy Sheridan, Ashok J. Kumar, Incidental white matter hyperintensities on magnetic resonance imaging in hiv-1 infection Journal of Acquired Immune Deficiency Syndromes. ,vol. 3, pp. 252- 259 ,(1990)
Strategies for Management of Antiretroviral Therapy (SMART) Study Group, None, CD4+ count-guided interruption of antiretroviral treatment. The New England Journal of Medicine. ,vol. 355, pp. 2283- 2296 ,(2006) , 10.1056/NEJMOA062360
Richard L. Kraus, Rodger Pasieczny, Karen Lariosa-Willingham, Mary S. Turner, Alice Jiang, John W. Trauger, Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. Journal of Neurochemistry. ,vol. 94, pp. 819- 827 ,(2005) , 10.1111/J.1471-4159.2005.03219.X
Beau Ances, Scott Letendre, Sarah Gibson, Ronald J Ellis, Neurologic complications of HIV disease and their treatment. Topics in HIV medicine : a publication of the International AIDS Society, USA. ,vol. 18, pp. 45- 55 ,(2010)
I. C. Anthony, S. N. Ramage, F. W. Carnie, P. Simmonds, J. E. Bell, Influence of HAART on HIV-Related CNS Disease and Neuroinflammation Journal of Neuropathology and Experimental Neurology. ,vol. 64, pp. 529- 536 ,(2005) , 10.1093/JNEN/64.6.529